Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Michael Nally

CEO at Generate Biomedicines, Inc. (GENB)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return+31.1%
vs. S&P 500+18.2%
Beat the market100%
Paper profit on buys+$47K
Total bought / sold$240K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Mar 6SEC GENBGenerate Biomedicines, Inc. Buy 20,000572,707 held (+4%) $12.00 $240K +19.5%
  • Buy

    CEO Michael Nally bought $240K of GENB at $12.00 — first open-market purchase in our records.